Literature DB >> 15533027

A meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose.

Benoit Bailey1, Nicholas A Buckley, Devendra K Amre.   

Abstract

OBJECTIVES: To systematically review and summarize studies on the accuracy of ECG and tricyclic antidepressant (TCA) concentration as prognostic indicators of the risk of seizures, ventricular arrhythmia (VA) or death in patients with TCA overdose.
METHODS: Articles were identified with MedLine and Cochrane register of controlled clinical trials searches and review of medical toxicology textbooks. Quality of the included studies was assessed. Pooled estimates of sensitivity, specificity, likelihood ratios and Summary Receiver Operating Characteristics (SROC) curves were generated.
RESULTS: A total of 18 studies were included in the analysis. The pooled sensitivity (Se) and specificity (Sp) of the QRS for predicting seizures were 0.69 [95% CI 0.57-0.78] and 0.69 [95% CI 0.58-0.78] as compared to 0.75 [95% CI 0.61-0.85] and 0.72 [95% CI 0.61-0.81] for the TCA concentration. The Se and Sp of the QRS to predict VA were 0.79 [95% CI 0.58-0.91] and 0.46 [95% CI 0.35-0.59] compared to 0.78 [95% CI 0.56-0.90] and 0.57 [95% CI 0.46-0.67] for the TCA concentration. The Se and Sp of the QRS to predict death were 0.81 [95% CI 0.54-0.94] and 0.62 [95% CI 0.55-0.68] compared to 0.76 [95% CI 0.49-0.91] and 0.60 [95% CI 0.47-0.72] for the TCA concentration. Very few studies evaluated the accuracy of QTc, T 40 ms axis and the R/S ratio.
CONCLUSIONS: Overall, the studies suggested that the ECG and TCA concentration have similar but relatively poor performance for predicting complications, such as seizures, VA or death, associated with TCA overdose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533027     DOI: 10.1081/clt-200035286

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  9 in total

1.  The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach.

Authors:  Lena E Friberg; Geoffrey K Isbister; L Peter Hackett; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

2.  Prolonged use of intravenous lipid emulsion in a severe tricyclic antidepressant overdose.

Authors:  Ravi Agarwala; Syed Zaki Ahmed; Timothy J Wiegand
Journal:  J Med Toxicol       Date:  2014-06

3.  Rapid diagnosis and treatment of severe tricyclic antidepressant toxicity.

Authors:  Simon Clark; Jerry W Catt; Terrell Caffery
Journal:  BMJ Case Rep       Date:  2015-10-14

Review 4.  Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.

Authors:  Jeffrey R Strawn; Laura Geracioti; Neil Rajdev; Kelly Clemenza; Amir Levine
Journal:  Expert Opin Pharmacother       Date:  2018-07       Impact factor: 3.889

Review 5.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

6.  Impaired heart rate variability and altered cardiac sympathovagal balance after antidepressant overdose.

Authors:  W S Waring; J Y Rhee; D N Bateman; G E Leggett; H Jamie
Journal:  Eur J Clin Pharmacol       Date:  2008-06-10       Impact factor: 2.953

Review 7.  Utility of the electrocardiogram in drug overdose and poisoning: theoretical considerations and clinical implications.

Authors:  Christopher Yates; Alex F Manini
Journal:  Curr Cardiol Rev       Date:  2012-05

8.  Options for treating postherpetic neuralgia in the medically complicated patient.

Authors:  Patricia Bruckenthal; Robert L Barkin
Journal:  Ther Clin Risk Manag       Date:  2013-08-19       Impact factor: 2.423

Review 9.  Extracorporeal treatment for tricyclic antidepressant poisoning: recommendations from the EXTRIP Workgroup.

Authors:  Christopher Yates; Tais Galvao; Kevin M Sowinski; Karine Mardini; Tudor Botnaru; Sophie Gosselin; Robert S Hoffman; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Semin Dial       Date:  2014-04-09       Impact factor: 3.455

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.